Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021		242,738,000
Beginning balance at Dec. 31, 2021	$ 929,787	$ 24	$ 1,515,748	$ (1,623)	$ (584,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)		1,710,000
Issuance of common stock upon exercise of stock options	2,555	$ 1	2,554
Stock-based compensation (in shares)		975,000
Stock-based compensation	22,028		22,028
Other comprehensive income	(4,977)			(4,977)
Net loss	(68,144)				(68,144)
Ending balance (in shares) at Mar. 31, 2022		245,423,000
Ending balance at Mar. 31, 2022	$ 881,249	$ 25	1,540,330	(6,600)	(652,506)
Beginning balance (in shares) at Dec. 31, 2022	249,567,343	249,567,000
Beginning balance at Dec. 31, 2022	$ 833,252	$ 25	1,608,306	(7,599)	(767,480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	0
Stock-based compensation	$ 13,882		13,882
Issuance of common stock in connection with restricted stock units, net of tax (in shares)		42,000
Issuance of common stock in connection with restricted stock units, net of tax	(69)		(69)
Other comprehensive income	3,720			3,720
Net loss	$ (66,959)				(66,959)
Ending balance (in shares) at Mar. 31, 2023	249,609,247	249,609,000
Ending balance at Mar. 31, 2023	$ 783,826	$ 25	$ 1,622,119	$ (3,879)	$ (834,439)